Reassessing the basic allowance for housing for Army personnel in a rapidly changing housing market

Abstract: Rising housing prices and inflation since 2020 have brought attention to the adequacy of the Basic Allowance for Housing (BAH) for military personnel. The authors of this report assess the adequacy of BAH and the BAH rate-setting methodology from the standpoint of Army personnel, in the context of recent changes in the housing market. The authors first assess the BAH methodology by considering the housing choices made by Army personnel and whether soldiers are making choices consistent with the way the allowance is set. They then assess the adequacy of BAH and the housing procured by members by using the 2017–2021 American Community Survey data to assess the extent to which the housing expenditures of active duty soldiers are comparable with those of income-matched civilians and civilians with comparable demographic characteristics. They also assess the extent to which there are observable differences between soldiers and civilians in neighborhood amenities across six exemplar installations. Finally, they assess the extent to which the BAH methodology adequately captured changes in housing prices, particularly given the dramatic increases in both rents and home sale prices in the years since the start of the coronavirus disease 2019 (COVID-19) pandemic.

Read the full article
Report a problem with this article

Related articles

  • More for Policy & Practice

    Temporal trends in opioid-related care and pain among Veterans at the end of life

    Abstract: Context: In response to the opioid crisis, federal guidelines were implemented, including the Veterans Health Administration's (VA) Opioid Safety Initiative in 2013. The impact of policies on patients near the end of life is unknown. Objective: Examine temporal trends in opioid prescribing, pain, and opioid overdoses among Veterans near the end of life. Methods: Retrospective, time series analysis of VA decedents between October 2009 and September 2018 whose next-of-kin participated in VA's Bereaved Family Survey (BFS). Using multivariate regression to adjust for sociodemographic and clinical covariates, we examined temporal trends in outpatient opioid prescribing, uncontrolled pain based on BFS report, and opioid overdose-related hospitalizations, in the last month of life, overall and by clinical diagnosis (cancer versus non-cancer). Results: Among 79,409 decedents, mean daily outpatient opioid dose in morphine milligram equivalents in the last month of life decreased from 4.6 mg in 2010 to 2.1 mg in 2018 (adjusted change -0.20 mg/year; P